Observational Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Asia. The aim of this observational study is to evaluate the
incidence of serious adverse drug reactions while using insulin detemir under normal clinical
practice conditions in the Gulf countries